Dr. Arash Zarrine-Afsar

UHN Techna Institute, University of Toronto

Advancing Cancer Therapeutics with Mass Spectrometry Tumor Analysis

Dr. Arash Zarrine-Afsar, Assistant Professor, Department of Medical Biophysics, Techna Institute for the Advancement of Technology for Health at the University of Toronto, explores the advantages of mass spectrometry imaging for tumor analysis. He discusses development of the technology for clinical applications, which could one day enhance therapeutic decisions.

LIKE 0


Dr. Arash Zarrine-Afsar
Mass Spectrometry

Dr. Arash Zarrine-Afsar

Biography

Dr. Arash Zarrine-Afsar is a Scientist at UHN’s Techna Institute. More
Follow Arash

Dr. Arash Zarrine-Afsar

UHN Techna Institute, University of Toronto

Dr. Arash Zarrine-Afsar is a Scientist at UHN’s Techna Institute. He is trained as a Physical Biochemist at the University of Toronto. Dr. Zarrine-Afsar’s long-term research interests revolve around developing new tools and techniques to study the dynamics of biological systems, in particular, the transition to the disease state. A multitude of biophysical imaging, spectroscopy and spectrometry techniques is used to reveal changes in cellular chemistry that correlate with the disease state (e.g. conformational dynamics of single molecules in isolation, or compositional dynamics of whole proteome/metabolome).